AGIO
Agios Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $2.52B | Price | $40.42 |
| Volume | 437.62K | Change | -6.53% |
| P/E Ratio | 3.7 | Open | $42.86 |
| Revenue | $36.5M | Prev Close | $43.24 |
| Net Income | $673.7M | 52W Range | $23.42 - $62.58 |
| Div Yield | N/A | Target | $47.17 |
| Overall | 80 | Value | 80 |
| Quality | 71 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyAgios Pharmaceuticals Inc. (AGIO) is a leading Healthcare company in the Biotechnology industry, currently trading at $40.41 with a market capitalization of $2.52 billion. The stock is trading in the middle of its 52-week range, demonstrating strong quality characteristics with a MarketXLS quality score of 71.
Today's trading session shows AGIO with a volume of 438K shares. The stock opened down 0.88% from yesterday's close of $43.24. Current analyst estimates project earnings of $-7.36 per share for this year, with next year targeting $-7.36.
AGIO demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including XNCR, EXEL, BMRN, PFE, GSK.
Key investment considerations for AGIO include excellent overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 16.7%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 09:24 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AGIO | $40.42 | -6.5% | 437.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Agios Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW